Cita APA (7a ed.)
Ruigrok, E. A. M., van Vliet, N., Dalm, S. U., de Blois, E., van Gent, D. C., Haeck, J., . . . Nonnekens, J. (2021). Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy. European Journal of Nuclear Medicine & Molecular Imaging, 48(5), 1339-1351.
Cita Chicago Style (17a ed.)
Ruigrok, Eline A. M., et al. "Extensive Preclinical Evaluation of Lutetium-177-labeled PSMA-specific Tracers for Prostate Cancer Radionuclide Therapy." European Journal of Nuclear Medicine & Molecular Imaging 48, no. 5 (2021): 1339-1351.
Cita MLA (9a ed.)
Ruigrok, Eline A. M., et al. "Extensive Preclinical Evaluation of Lutetium-177-labeled PSMA-specific Tracers for Prostate Cancer Radionuclide Therapy." European Journal of Nuclear Medicine & Molecular Imaging, vol. 48, no. 5, 2021, pp. 1339-1351.
Precaución: Estas citas no son 100% exactas.